Literature DB >> 10838444

Time-Resolved Fluorescence Energy Transfer DNA Helicase Assays for High Throughput Screening.

.   

Abstract

DNA helicases are responsible for the unwinding of double-stranded DNA, facilitated by the binding and hydrolysis of 5'-nucleoside triphosphates. These enzymes represent an important class of targets for the development of novel anti-infective agents particularly because opportunity exists for synergy with existing therapies targeted at other enzymes involved in DNA replication. Unwinding reactions are conventionally monitored by low throughput, gel-based radiochemical assays; to overcome the limitations of low throughput to achieve comprehensive characterization of adenosine triphosphate (ATP)-dependent unwinding by viral and bacterial helicases and the screening for unwinding inhibitors, we have developed and validated homogeneous time-resolved fluorescence energy transfer (TRET) assays. Rapid characterization and screening of DNA helicase has been performed in 96- and 384-well plate densities, and the ability to assay in 1536-well format also demonstrated. We have successfully validated and are running full high throughput runs using 384-well TRET helicase assays, culminating in the identification of a range of chemically diverse inhibitors of viral and bacterial helicases. For screening in mixtures, we used a combination of quench correction routines and confirmatory scintillation proximity (SP) assays to eliminate false-positives due to the relatively high levels of compound quenching (unlike other Ln(3+)-based assays). This strategy was successful yet emphasised the need for further improvements in helicase assays.

Entities:  

Year:  1999        PMID: 10838444     DOI: 10.1177/108705719900400505

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  13 in total

1.  Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activities.

Authors:  Bing Li; Ramdas Pai; Ming Di; Daniel Aiello; Marjorie H Barnes; Michelle M Butler; Tommy F Tashjian; Norton P Peet; Terry L Bowlin; Donald T Moir
Journal:  J Med Chem       Date:  2012-12-11       Impact factor: 7.446

Review 2.  Progress in lanthanides as luminescent probes.

Authors:  I Hemmilä; V Laitala
Journal:  J Fluoresc       Date:  2005-07       Impact factor: 2.217

Review 3.  Insight into the biochemical mechanism of DNA helicases provided by bulk-phase and single-molecule assays.

Authors:  Piero R Bianco
Journal:  Methods       Date:  2021-12-08       Impact factor: 4.647

Review 4.  Helicases as antiviral drug targets.

Authors:  David N Frick
Journal:  Drug News Perspect       Date:  2003 Jul-Aug

5.  Monitoring helicase activity with molecular beacons.

Authors:  Craig A Belon; David N Frick
Journal:  Biotechniques       Date:  2008-10       Impact factor: 1.993

6.  Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.

Authors:  Daniel Aiello; Marjorie H Barnes; Esther E Biswas; Subhasis B Biswas; Shen Gu; John D Williams; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem       Date:  2009-05-12       Impact factor: 3.641

7.  Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit.

Authors:  Bing Li; Ramdas Pai; Daniel Aiello; Ming Di; Marjorie H Barnes; Norton P Peet; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem Lett       Date:  2013-04-30       Impact factor: 2.823

Review 8.  Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.

Authors:  Andrew Robinson; Rebecca J Causer; Nicholas E Dixon
Journal:  Curr Drug Targets       Date:  2012-03       Impact factor: 3.465

Review 9.  Discovering new medicines targeting helicases: challenges and recent progress.

Authors:  William R Shadrick; Jean Ndjomou; Rajesh Kolli; Sourav Mukherjee; Alicia M Hanson; David N Frick
Journal:  J Biomol Screen       Date:  2013-03-27

Review 10.  A new helicase assay based on graphene oxide for anti-viral drug development.

Authors:  Hongje Jang; Soo-Ryoon Ryoo; Min Jae Lee; Sang Woo Han; Dal-Hee Min
Journal:  Mol Cells       Date:  2013-03-11       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.